Hanna Sartor

Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study

2023 · 439 Zit. · The Lancet Oncology

Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial

2026 · 4 Zit. · The Lancet

The Safety of an Artificial Intelligence Supported Screen-Reading Procedure Versus Standard Double Reading in the Mammography Screening with Artificial Intelligence (MASAI) Trial: A Randomised, Controlled, Screening Accuracy Study

2023 · 0 Zit. · SSRN Electronic Journal